Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516781 | SCV000612826 | benign | not specified | 2017-07-26 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000516781 | SCV000711942 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Met562Thr in exon 16 of CLCNKB: This variant is not expected to have clinical significance because it has been identified in 98.02% (65150/66466) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitut e.org; dbSNP rs5253). |
Genome- |
RCV001579038 | SCV001806429 | benign | Bartter disease type 4B | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001579039 | SCV001806430 | benign | Bartter disease type 3 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001683550 | SCV001900005 | benign | not provided | 2018-11-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001683550 | SCV002354241 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001683550 | SCV005283210 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000516781 | SCV001744086 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000516781 | SCV001956400 | benign | not specified | no assertion criteria provided | clinical testing |